XML 31 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 7 - Stockholders' Equity (Tables)
3 Months Ended
Sep. 30, 2018
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
Weighted
Average,
September 30,
2018
   
 
Range,
September 30,
2018
   
Weighted
Average,
September 30,
2017
   
 
Range,
September 30,
2017
 
Volatility
   
70
%  
 63%
-
76%
     
-
     
-
 
Dividend yield
   
-
   
 
-
 
     
-
     
-
 
Risk-free interest rate
   
2.73
%  
 2.68%
-
2.78%
     
-
     
-
 
Expected term (years)
   
3.9
   
 3.4
to
4.3
     
-
     
-
 
Share-based Compensation, Stock Options, Activity [Table Text Block]
   
 
 
 
 
Options
   
 
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life
   
 
 
Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2018
   
6,827,225
    $
1.11
     
3.8
    $
-
 
Granted
   
325,000
     
0.68
     
 
     
 
 
Exercised
   
-
     
-
     
 
     
 
 
Forfeited
   
-
     
-
     
 
     
 
 
Expired
   
-
     
-
     
 
     
 
 
Outstanding at September 30, 2018
   
7,152,225
    $
1.10
     
3.8
    $
-
 
Exercisable at September 30, 2018
   
7,002,225
    $
1.11
     
3.8
    $
-
 
Schedule of Nonvested Share Activity [Table Text Block]
   
 
 
Options
   
Weighted Average
Grant-Date Fair
Value
 
Nonvested at July 1, 2018
   
-
    $
-
 
Granted
   
325,000
     
0.36
 
Vested
   
(175,000
)    
0.46
 
Nonvested at September 30, 2018
   
150,000
    $
0.25
 
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
   
Three months
ended
September 30,
2018
   
Three months
ended
September 30,
2017
 
General and administrative:
               
Fair value of stock/warrant bonuses expensed
  $
-
    $
4,133
 
Change in fair value from modification of option terms
   
211,185
     
-
 
Change in fair value from modification of warrant terms
   
118,233
     
-
 
Fair value of stock options expensed
   
69,625
     
2,300
 
Total
  $
399,043
    $
6,433
 
                 
Research and development:
               
Fair value of stock bonus expensed
  $
-
    $
7,027
 
Change in fair value from modification of option terms
   
11,115
     
-
 
Change in fair value from modification of warrant terms
   
44,793
     
-
 
Fair value of stock options expensed
   
25,875
     
-
 
Total
  $
81,783
    $
7,027